Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: A report from the National Down Syndrome Project

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 10, 2011, Pages 885-893

  Bean, Lora J H ^a   Allen, Emily G ^a   Tinker, Stuart W ^a   Hollis, Natasha D ^a   Locke, Adam E ^a   Druschel, Charlotte ^b   Hobbs, Charlotte A ^c   O'Leary, Leslie ^d   Romitti, Paul A ^e   Royle, Marjorie H ^f   Torfs, Claudine P ^g   Dooley, Kenneth J ^h   Freeman, Sallie B ^a   Sherman, Stephanie L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^g PUBLIC HEALTH INSTITUTE   (United States)

^h SIBLEY HEART CENTER CARDIOLOGY   (United States)

Author keywords

Atrial septal defect; Atrioventricular septal defect; Congenital heart defect; Down syndrome; Folic acid

Indexed keywords

FOLIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONCEPTION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DOWN SYNDROME; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FALLOT TETRALOGY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL SMOKING; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; VITAMIN SUPPLEMENTATION;

DIETARY SUPPLEMENTS; DOWN SYNDROME; FEMALE; FOLIC ACID; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; MALE; PREGNANCY; UNITED STATES;

EID: 80053937529     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.22848     Document Type: Article

References (50)

1. Bailey LB, Berry RJ. 2005. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81: 1213S-1217S.
2. Ballweg JA, Wernovsky G, Gaynor JW, et al. 2007. Neurodevelopmental outcomes following congenital heart surgery. Pediatr Cardiol 28: 126-133.
3. Bernstein BE, Meissner A, Lander ES., et al. 2007. The mammalian epigenome. Cell 128: 669-681.
4. Besser LM, Williams LJ, Cragan JD, et al. 2007. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Res A Clin Mol Teratol 79: 730-736.
5. Botto LD, Khoury MJ, Mulinare J, et al. 1996. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98: 911-917.
6. Botto LD, Olney RS, Erickson JD, et al. 2004. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 125: 12-21.
7. Brandalize AP, Bandinelli E, dos Santos PA, et al. 2009. Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. Am J Med Genet A149: 2080-2087.
8. Canfield MA, Marengo L, Ramadhani TA, et al. 2009. The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol 23: 41-50.
9. Carmichael SL, Shaw GM, Song J, et al. 2008. Markers of acculturation and risk of NTDs among Hispanic women in California. Birth Defects Res A Clin Mol Teratol 82: 755-762.
10. Centers for Disease Control and Prevention. 1992. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41(RR-14): 1-7.
11. Chadefaux B, Rethore MO, Raoul O, et al. 1985. Cystathionine beta synthase: gene dosage effect in trisomy 21. Biochem Biophys Res Commun 128: 40-44.
12. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
13. de Rubens Figueroa J, del Pozzo Magana B, Pablos Hach JL, et al. 2003. Heart malformations in children with Down syndrome. Rev Esp Cardiol 56: 894-899.
14. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. eds. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981-1989. Armonk NY: Futura Publishing Co., Inc., 1997. Perspectives in Pediatric Cardiology. No. 5.
15. Freeman SB, Allen EG, Oxford-Wright CL, et al. 2007. The National Down Syndrome Project: design and implementation. Public Health Rep 122: 62-72.
16. Freeman SB, Bean LH, Allen EG, et al. 2008. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med 10: 173-180.
17. Freeman SB, Taft LF, Dooley KJ, et al. 1998. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 80: 213-217.
18. Frid C, Drott P, Otterblad Olausson P, et al. 2004. Maternal and neonatal factors and mortality in children with Down syndrome born in 1973-1980 and 1995-1998. Acta Paediatr 93: 106-112.
19. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
20. Ganji V, Kafai MR. 2006. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the United States: analysis of data from National Health and Nutrition Examination Surveys, 1988-1994, 1999-2000, and 2001-2002. J Nutr 136: 153-158.
21. Goldmuntz E, Woyciechowski S, Renstrom D, et al. 2008. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1: 126-132.
22. Harmon DL, Shields DC, Woodside JV, et al. 1999. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17: 298-309.
23. Hassold TJ, Jacobs PA. 1984. Trisomy in man. Annu Rev Genet 18: 69-97.
24. Hobbs CA, James SJ, Parsian A, et al. 2006. Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene. J Med Genet 43: 162-166.
25. Kallen B, Mastroiacovo P, Robert E, et al. 1996. Major congenital malformations in Down syndrome. Am J Med Genet 65: 160-166.
26. Kant AK, Graubard BI. 2007. Ethnicity is an independent correlate of biomarkers of micronutrient intake and status in American adults. JNutr 137: 2456-2463.
27. Locke AE, Dooley KJ, Tinker SW, et al. 2010. Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol 34: 613-623.
28. Martin JA, Hamilton BE, Sutton PD, et al. 2007. Births: final data for 2005. Natl Vital Stat Rep 56: 1-103.
29. Martinez Frias ML, Parralo JA, Salvador J, et al. 1986. Sex ratios in neural tube defects. Lancet 2: 871-872.
30. McBride KL, Fernbach S, Menesses A, et al. 2004. A family-based association study of congenital left-sided heart malformations and 5, 10 methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 70: 825-830.
31. Meijer WM, Werler MM, Louik C, et al. 2006. Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol Teratol 76: 714-717.
32. Mitchell LE, Long J, Garbarini J, et al. 2010. Variants of folate metabolism genes and risk of left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol 88: 48-53.
33. Pei L, Zhu H, Zhu J, et al. 2006. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol 16: 352-356.
34. Pogribna M, Melnyk S, Pogribny I, et al. 2001. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69: 88-95.
35. Sadler TW. 2005. Langman's essential medical embryology. Philidelphia: Lippincott Williams and Wilkins.
36. Scanlon KS, Ferencz C, Loffredo CA, et al. 1998. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 9: 95-98.
37. Seller MJ. 1986. Neural tube defects and sex ratios. Lancet 2: 227.
38. Shaw GM, Iovannisci DM, Yang W, et al. 2005. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 138: 21-26.
39. Shaw GM, O'Malley CD, Wasserman CR, et al. 1995. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59: 536-545.
40. Shaw GM, Zhu H, Lammer EJ, et al. 2003. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 158: 747-752.
41. Shin M, Kucik JE, Correa A, et al. 2007. Causes of death and case fatality rates among infants with Down syndrome in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol 79: 775-780.
42. van Beynum IM, Kapusta L, Bakker MK, et al. 2010. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 31: 464-471.
43. van Beynum IM, Kouwenberg M, Kapusta L, et al. 2006. MTRR 66A>G polymorphism in relation to congenital heart defects. Clin Chem Lab Med 44: 1317-1323.
44. van der Put NM, van der Molen EF, Kluijtmans LA, et al. 1997. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 90: 511-517.
45. Velie EM, Shaw GM, Malcoe LH, et al. 2006. Understanding the increased risk of neural tube defect-affected pregnancies among Mexico-born women in California: immigration and anthropometric factors. Paediatr Perinat Epidemiol 20: 219-230.
46. Vida VL, Barnoya J, Larrazabal LA, et al. 2005. Congenital cardiac disease in children with Down's syndrome in Guatemala. Cardiol Young 15: 286-290.
47. Wald NN, Sneddon JJ. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338: 131-137.
48. Weisberg I, Tran P, Christensen B, et al. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172.
49. Williams LJ, Rasmussen SA, Flores A, et al. 2005. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 116: 580-586.
50. Yang QH, Carter HK, Mulinare J, et al. 2007. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 85: 1409-1416.